• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

Comprehensive Analysis of 3,5-Dibromoanthranilamide (CAS No. 16524-04-2): Properties, Applications, and Industry Trends

3,5-Dibromoanthranilamide (CAS No. 16524-04-2) is a halogenated organic compound with significant relevance in pharmaceutical and agrochemical research. This brominated anthranilamide derivative has garnered attention due to its unique molecular structure, characterized by two bromine atoms positioned at the 3rd and 5th carbon atoms of the anthranilamide backbone. Researchers frequently explore its synthetic pathways and bioactive potential, particularly in the context of crop protection agents and medicinal chemistry intermediates.

In recent years, the demand for specialty chemicals like 3,5-Dibromo-2-aminobenzamide (an alternative nomenclature) has surged, driven by advancements in green chemistry and sustainable synthesis. Laboratories increasingly prioritize compounds with high purity grades (>98%) for precision applications. The compound’s crystalline solid form and moderate solubility in polar solvents make it versatile for multi-step organic synthesis.

One of the most searched questions regarding CAS 16524-04-2 relates to its structure-activity relationship (SAR). Studies suggest that the bromine substituents enhance electron-withdrawing effects, influencing binding affinity in enzyme inhibition studies. This property is particularly valuable in designing next-generation fungicides, aligning with the agricultural sector’s focus on resistance management.

The compound’s thermal stability (decomposition point >200°C) and HPLC analysis methods are frequently discussed in technical forums. Analytical chemists emphasize the importance of reverse-phase chromatography for quantifying trace impurities, a critical factor for GMP-compliant production. Recent patents highlight its utility as a key intermediate in heterocyclic compound synthesis, especially for fused ring systems with potential biopharmaceutical applications.

Environmental considerations have propelled research into eco-friendly bromination techniques for producing 3,5-Dibromoanthranilamide. Innovations such as catalytic bromination using N-bromosuccinimide (NBS) reduce hazardous byproducts, addressing the industry’s shift toward green manufacturing protocols. Regulatory databases like REACH provide updated safety data sheets, ensuring compliance with international chemical standards.

Market analysts note growing interest in custom synthesis services for this compound, particularly from contract research organizations (CROs). Its role in developing antiviral scaffolds has gained traction post-pandemic, with molecular docking studies exploring its protease inhibitor potential. The global fine chemicals market projects a 6.2% CAGR for similar halogenated intermediates through 2030.

Quality control protocols for 16524-04-2 emphasize spectroscopic characterization (1H/13C NMR, FT-IR) and elemental analysis. Suppliers increasingly provide batch-specific COAs (Certificates of Analysis) to meet pharmaceutical excipient standards. Storage recommendations typically suggest amber glass containers under inert atmosphere to preserve long-term stability.

Emerging applications include its use in photoactive materials research, where the bromine-heavy structure demonstrates unique UV absorption properties. Materials scientists are investigating its incorporation into organic semiconductors for optoelectronic devices, coinciding with the rise of flexible electronics technologies.

For researchers sourcing 3,5-Dibromoanthranilamide, critical parameters include residual solvent levels (tested via GC-MS) and heavy metal content (ICP-OES analysis). The compound’s logP value (~2.8) indicates favorable membrane permeability, explaining its utility in drug discovery pipelines. Recent publications in ACS journals detail novel microwave-assisted synthesis routes that improve yield by 18-22% compared to traditional methods.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)